ACC

Bristol Myers Squibb to Present Data at the American College of Cardiology Annual Scientific Session 2024 Reinforcing Extensive Body of Evidence in Clinical and Real-World Settings Across Cardiovascular Portfolio

Retrieved on: 
Monday, March 25, 2024
Health, Clinical Trials, General Health, Pharmaceutical, Cardiology, Biotechnology, BMY, Patient, Mitigation, Bristol Myers Squibb, MD, Senior, LVEF, American College, Safety, REMS, ACC, Risk, Hospital, Pharmaceutical industry

Bristol Myers Squibb (NYSE: BMY) today announced the presentation of data at the American College of Cardiology (ACC) Annual Scientific Session & Expo, taking place April 6-8, 2024 in Atlanta, Georgia.

Key Points: 
  • Bristol Myers Squibb (NYSE: BMY) today announced the presentation of data at the American College of Cardiology (ACC) Annual Scientific Session & Expo, taking place April 6-8, 2024 in Atlanta, Georgia.
  • These data are consistent with the clinical development program and reinforce the safety profile of CAMZYOS in clinical practice.
  • This effectiveness and safety information about ELIQUIS use in clinical practice can supplement data from randomized clinical trials.
  • Visit this page on BMS.com for more information on Bristol Myers Squibb’s scientific approach and resources on cardiovascular diseases.

MACOM to Showcase 200G per Lane Products at Optical Fiber Communication Conference and Exhibition (OFC)

Retrieved on: 
Thursday, March 21, 2024
Technology, Semiconductor, Security, Satellite, Photography, Telecommunications, Nanotechnology, Software, Audio, Video, VoIP, Networks, Internet, Mobile, Wireless, Hardware, Electronic Design Automation, Data Management, Consumer Electronics, Cloud, Optics, Conference, DSP, MSA, DRIVE, LPO, Copper, AEC, PURE, DAC, Ecosystem, PON, TB, ACC, Data-rate units, TIDEL Park Coimbatore, Mobile phone

MACOM Technology Solutions Inc. (“MACOM”) today announced that it will host live demonstrations of its products at the Optical Fiber Communication Conference and Exposition (“OFC”) in San Diego, California, March 26 – 28, 2024, Booth #3025.

Key Points: 
  • MACOM Technology Solutions Inc. (“MACOM”) today announced that it will host live demonstrations of its products at the Optical Fiber Communication Conference and Exposition (“OFC”) in San Diego, California, March 26 – 28, 2024, Booth #3025.
  • These demonstrations feature advancements in 200G per lane technology, along with new product additions to its portfolio of optical, high-speed analog and mixed signal solutions.
  • 200G per Lane Live Demonstrations Include:
    MACOM PURE DRIVETM 200 Gbps per Lane Linear Drive: MACOM is extending the capabilities of its MACOM PURE DRIVE portfolio to 212 Gbps per lane to enable the development of 1.6TB linear pluggable optical (“LPO”) modules.
  • MACOM PURE DRIVE removes DSP from optical modules and provides industry-leading low power, low latency solutions for optical communications for both single-mode and multi-mode fibers.

Alnylam to Webcast Investor Event to Discuss Results from KARDIA-2 Phase 2 Study of Zilebesiran at American College of Cardiology Scientific Session

Retrieved on: 
Wednesday, March 20, 2024
Science, Cardiology, Biotechnology, Research, Pharmaceutical, Managed Care, Health, Clinical Trials, Q&A, Medication, Webcast, Alnylam Pharmaceuticals, Angiotensin, American College, RNA interference, Therapy, AGT, ACC, Cardiomyopathy, Hypertension

The event will include presentations and a Q&A session with Alnylam management and Akshay Desai, M.D., Director of the Cardiomyopathy and Heart Failure Program, Brigham and Women’s Hospital.

Key Points: 
  • The event will include presentations and a Q&A session with Alnylam management and Akshay Desai, M.D., Director of the Cardiomyopathy and Heart Failure Program, Brigham and Women’s Hospital.
  • A replay of the call will be available two hours after the call and archived on the same webpage for six months.
  • A live audio webcast of the call will be available on the Investors section of the Company’s website at www.alnylam.com/events .
  • An archived webcast will be available on the Company’s website approximately two hours after the event.

Cardio Diagnostics Holdings, Inc. to Showcase HeartRisk and Actionable Clinical Intelligence Version 3 at the American College of Cardiology’s 73rd Annual Scientific Session

Retrieved on: 
Thursday, March 14, 2024
Other Health, Software, General Health, Data Management, Medical Devices, Technology, Artificial Intelligence, Health Technology, Cardiology, Biotechnology, Other Technology, Health, Cardio, Genomics, Organization, Cardiovascular disease, ACI, Entrepreneurship, Patient, Artificial intelligence, Medicine, CHD, American College, Heart, Epigenomics, Moyamoya disease, ACC, Pharmaceutical industry

Cardio Diagnostics' mission is in lockstep with this year's ACC.24 conference theme, "Advancing Cardiovascular Care for All."

Key Points: 
  • Cardio Diagnostics' mission is in lockstep with this year's ACC.24 conference theme, "Advancing Cardiovascular Care for All."
  • All attendees including providers, provider organizations and potential industry partners will be able to learn more about Cardio Diagnostics' HeartRisk and Actionable Clinical Intelligence platforms at booth 3605.
  • Actionable Clinical Intelligence V.3: Building upon the success of its predecessor, which debuted at ACC in 2023, Actionable Clinical Intelligence V.3 takes precision medicine to new heights.
  • "Our new innovative solutions, HeartRisk and Actionable Clinical Intelligence V.3, can potentially revolutionize how healthcare professionals approach cardiovascular disease prevention, detection and management.

Edna’s Non-Alcoholic Cocktail Co to Showcase its Internationally Award Winning Non-Alcoholic Cocktails at Natural Products Expo West 2024

Retrieved on: 
Thursday, March 14, 2024
Retail, Specialty, Food, Beverage, Wine & Spirits, RTD, Taste, Growth, Toronto Star, Vancouver Magazine, Energy drink, Traction, ACC, Liquor

Edna’s Non-Alcoholic Cocktail Co, a leading innovator in the consumer non-alcoholic beverages sector, is thrilled to announce its participation in Natural Products Expo West, to be held at the Anaheim Convention Center from March 13th to March 15th, 2024.

Key Points: 
  • Edna’s Non-Alcoholic Cocktail Co, a leading innovator in the consumer non-alcoholic beverages sector, is thrilled to announce its participation in Natural Products Expo West, to be held at the Anaheim Convention Center from March 13th to March 15th, 2024.
  • This year, Edna’s Non-Alcoholic Cocktail Co will be showcasing its latest award winning RTD (ready to drink) cocktails, crafted with a commitment to quality ingredients and exceptional taste.
  • Attracting over 65,000 attendees, the Expo West platform provides an excellent opportunity for industry professionals, retailers, and investors, to experience firsthand the unparalleled flavors and versatility of Edna’s offerings.
  • In addition to its participation in Natural Products Expo West, Edna’s is excited to announce its entry into the US market.

Global and China Two-wheeler Intelligence and Industry Chain Research Report 2023 Featuring 11 Motorcycle Companies, 10 E2W Companies and 20 Two-wheeler Intelligent Industry Chain Companies - ResearchAndMarkets.com

Retrieved on: 
Monday, March 11, 2024
Technology, Other Automotive, Other Technology, Automotive, Cloud, OTA, Communication, Intelligence, Motorcycle, Internet of things, Niu Technologies, Tier 1, Visteon, BSD, QJ, Internet, Electronics, ADAS, Artificial intelligence, Foot, FCW, AI, Software, Hope, Qianjiang Motorcycle, Big data, Huawei, ABS, Radar, Safety, Valeo, APP, Language, ACC, HarmonyOS, Human, Internet service provider

The "Two-wheeler Intelligence and Industry Chain Research Report, 2023" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Two-wheeler Intelligence and Industry Chain Research Report, 2023" report has been added to ResearchAndMarkets.com's offering.
  • Based on the successful experience in vehicle intelligence, some automakers therefore have begun to deploy two-wheelers in hope of expanding new business amid the automotive market saturation.
  • For example, in September 2023 Qianjiang Motorcycle released QJ PILOT, an AI-driven riding assistance system which combines intelligent hardware and software.
  • Moreover, in the future, ever more two-wheelers will have interconnection functions, such as intelligent interconnection, OTA, voice interaction, face recognition and gesture control.

The Big College Challenge: Money How We Can Make College Affordable for Everyone

Retrieved on: 
Thursday, April 4, 2024
Face, University, Learning, Education, Community college, AACC, Poverty, Student, American Dream, Austin Community College District, Workforce, Trustee, Multimedia, GED, ACC, Human, Nursing

AUSTIN, Texas, April 4, 2024 /PRNewswire/ -- When I first came to Austin Community College District (ACC) in fall 2023, I knew I wanted to get to know our students and learn about our community. What I discovered wasn't a surprise, but it was unsettling. 

Key Points: 
  • People are experiencing a life that's not affordable, and they can't find a way to climb out and up.
  • We have been asking students to mortgage their future — to take on big loan debt.
  • So, we asked ourselves at ACC: If we can eliminate that barrier, can we make college a reality for more people?
  • With the support of our board of trustees, Austin Community College will pilot the ACC Free Tuition Program.

V-Wave to Present Late-Breaking Data from Pivotal RELIEVE-HF Study at American College of Cardiology Annual Scientific Session & Expo

Retrieved on: 
Thursday, March 28, 2024
Patient, Hospital, Heart failure, American College, Death, ACC, Heart, Jugular venous pressure, Pharmaceutical industry

CAESAREA, Israel, March 28, 2024 /PRNewswire/ -- V-Wave today announced it will present late-breaking data from its RELIEVE-HF pivotal trial at the American College of Cardiology's (ACC) Annual Scientific Session & Expo taking place April 6-8 in Atlanta.

Key Points: 
  • CAESAREA, Israel, March 28, 2024 /PRNewswire/ -- V-Wave today announced it will present late-breaking data from its RELIEVE-HF pivotal trial at the American College of Cardiology's (ACC) Annual Scientific Session & Expo taking place April 6-8 in Atlanta.
  • RELIEVE-HF is a randomized, double-blind, placebo-procedure-controlled, multicenter, multinational, pivotal trial of the
    V-Wave® Ventura® Interatrial Shunt in symptomatic patients with reduced (HFrEF) or preserved (HFpEF) left ventricular ejection fraction at high risk of heart failure (HF)-related events.
  • "We're pleased to present the RELIEVE-HF data at this year's ACC meeting, as we continue to advance this important technology with the goal of bringing a much-needed treatment option to patients with advanced heart failure, a leading cause of death and hospitalization in the U.S. and worldwide," said Neal Eigler, M.D., CEO of V-Wave.

Aker Carbon Capture announces agreement to form Joint Venture with SLB

Retrieved on: 
Thursday, March 28, 2024
Carbon, FEED, Growth, Cognite, Aker Solutions, Partnership, Area studies, SLB, NOK, CO2, CCUS, USD, ACC, Renewable energy

OSLO, Norway, March 27, 2024 /PRNewswire/ -- Aker Horizons ASA's (OSE: "AKH") portfolio company Aker Carbon Capture ASA ("ACC" and "the Company"), together with SLB, announced today an agreement to combine their respective carbon capture businesses to support accelerated industrial decarbonization at scale.

Key Points: 
  • OSLO, Norway, March 27, 2024 /PRNewswire/ -- Aker Horizons ASA's (OSE: "AKH") portfolio company Aker Carbon Capture ASA ("ACC" and "the Company"), together with SLB, announced today an agreement to combine their respective carbon capture businesses to support accelerated industrial decarbonization at scale.
  • We can think of no better partner than SLB to rapidly scale cost-effective solutions across the carbon capture value chain," said Aker Horizons CEO and Aker Carbon Capture Chairman Kristian Røkke.
  • Aker Carbon Capture and SLB will benefit from having a highly complementary carbon capture technology portfolio and a broader geographical presence.
  • Following the transaction, Aker Horizons will continue to support ACC as a partner with SLB in the carbon capture business.

Aker Carbon Capture Announces Agreement to form Joint Venture with SLB

Retrieved on: 
Wednesday, March 27, 2024
Carbon, International Energy Agency, Partnership, SLB, Bank statement, NOK, Capital market, CO2, CCUS, IEA, USD, ACC

OSLO, Norway, March 27, 2024 /PRNewswire/ -- Aker Carbon Capture ASA (OSLO: ACC) today announced an agreement with SLB to combine their respective carbon capture businesses to support accelerated industrial decarbonization at scale.

Key Points: 
  • OSLO, Norway, March 27, 2024 /PRNewswire/ -- Aker Carbon Capture ASA (OSLO: ACC) today announced an agreement with SLB to combine their respective carbon capture businesses to support accelerated industrial decarbonization at scale.
  • "The decision to combine ACC and SLB's carbon capture business is underpinned by a strategic vision that reflects our commitment to accelerate the industrial adoption of carbon capture," said Egil Fagerland, chief executive officer, ACC.
  • "By partnering with SLB, we will become a diversified, global carbon capture player.
  • At closing, SLB will pay NOK 4.12 billion in cash to ACC for the purchase of 80% of the shares in Aker Carbon Capture Holding AS (ACCH), which holds the business of ACC.